SCOR
Press Release
January 21, 2021 - N° 02
SCOR develops an innovative biometric risk calculator
to improve the underwriting process
Though the Life insurance underwriting process is simple and straightforward for healthy customers, it can be long and complicated for those with pre-existing conditions. Underwriters must examine such cases in depth, applying higher, sometimes excessive rates and even refusing cover.
SCOR’s latest digital innovation, Vitae, addresses these key underwriting complexities through the automation of the risk assessment process. Vitae is a cutting-edge biometric risk calculator based on advances in medical research and employing innovative Machine Learning techniques. The automation enables more accurate risk assessment based on a wider array of medical factors and simplifies the underwriting process, ultimately yielding a better experience – and a greater potential for solutions – for end customers.
Vitae, with its flagship calculator Vitae CVR for cardiovascular risk, is embedded in SCOR’s underwriting manual, SOLEM. Vitae CVR is also proposed as an e-underwriting solution for SCOR clients.
Paolo de Martin, CEO of SCOR Global Life, comments : “Improving Life insurance options for people who are not in ‘perfect health’ is at the heart of SCOR’s inclusive approach to underwriting. With Vitae, we reinvent the underwriting approach by leveraging vast amounts of data and Artificial Intelligence, to provide as many people as possible with protection against the risks they face.”
*
* *
Contact details
Communications
Jérôme Guilbert
+33 (0)1 58 44 79 19
jguilbert@scor.com
Investor Relations
Olivier Armengaud
+33 (0)1 58 44 86 12
oarmengaud@scor.com
LinkedIn: SCOR | Twitter: @SCOR_SE
Forward-looking statements
SCOR does not communicate "profit forecasts" in the sense of Article 2 of (EC) Regulation n°809/2004 of the European Commission. Thus, any forward-looking statements contained in this communication should not be held as corresponding to such profit forecasts. Information in this communication may include "forward-looking statements", including but not limited to statements that are predictions of or indicate future events, trends, plans or objectives, based on certain assumptions and include any statement which does not directly relate to a historical fact or current fact. Forward-looking statements are typically identified by words or phrases such as, without limitation, "anticipate", "assume", "believe", "continue", "estimate", "expect", "foresee", "intend", "may increase" and "may fluctuate" and similar expressions or by future or conditional verbs such as, without limitations, "will", "should", "would" and "could." Undue reliance should not be placed on such statements, because, by their nature, they are subject to known and unknown risks, uncertainties and other factors, which may cause actual results, on the one hand, to differ from any results expressed or implied by the present communication, on the other hand.
Please refer to the 2019 Universal Registration Document filed on March 13, 2020, under number D.20-0127 with the French Autorité des marchés financiers (AMF) posted on SCOR’s website www.scor.com (the “Document d’enregistrement universel”), for a description of certain important factors, risks and uncertainties that may affect the business of the SCOR Group. As a result of the extreme and unprecedented volatility and disruption of the current global financial crisis, SCOR is exposed to significant financial, capital market and other risks, including movements in interest rates, credit spreads, equity prices, and currency movements, changes in rating agency policies or practices, and the lowering or loss of financial strength or other ratings.
The Group’s financial information is prepared on the basis of IFRS and interpretations issued and approved by the European Union. This financial information does not constitute a set of financial statements for an interim period as defined by IAS 34 “Interim Financial Reporting”.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Scandinavian Investment Group A/S19.9.2025 20:22:33 CEST | Pressemeddelelse
Resultat aktietilbagekøbsprogram 17-19 september 2025
Kensana Health Inc.19.9.2025 19:29:40 CEST | Press release
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
Digitalist Group Oyj19.9.2025 19:00:31 CEST | Press release
Digitalist Group structures its financing
Leading Edge Materials Corp.19.9.2025 18:00:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2025
Sironax19.9.2025 17:00:00 CEST | Press release
Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom